Share Name Share Symbol Market Type
Rockwell Medical Inc NASDAQ:RMTI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.24 -8.45% 2.60 2.57 2.85 2.90 2.60 2.87 346,044 00:48:29

Rockwell Medical Shares Up 23% After Sun Pharma Licensing Deal

15/01/2020 6:11pm

Dow Jones News

Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart

1 Month : From Dec 2019 to Jan 2020

Click Here for more Rockwell Medical Charts.

By Chris Wack


Rockwell Medical Inc. (RMTI) shares rose 23% to $2.85 after the company said it has entered into license and supply agreements with a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. (524715.BY) for the rights to commercialize Triferic ferric pyrophosphate citrate in India.

Rockwell Medical said Sun Pharma will be the exclusive development and commercialization partner for Triferic in India, and Rockwell Medical will supply the product to Sun Pharma.

In consideration for the license, Rockwell Medical said it will receive an upfront fee, and will be eligible for milestone payments and royalties on net sales.

Rockwell Medical said a joint alliance committee, comprised of members from Rockwell Medical and Sun Pharma, will guide the development and execution for Triferic in India. Sun Pharma will be responsible for all clinical, regulatory and commercialization activities.


Write to Chris Wack at


(END) Dow Jones Newswires

January 15, 2020 12:56 ET (17:56 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

1 Year Rockwell Medical Chart

1 Year Rockwell Medical Chart

1 Month Rockwell Medical Chart

1 Month Rockwell Medical Chart
Your Recent History
Rockwell M..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200118 02:51:47